Protalix BioTherapeutics, Inc. financial data

Symbol
PLX on NYSE
Industry
Biological Products, (No Diagnostic Substances)
Location
2 University Plaza, Suite 100, Hackensack, NJ
State of incorporation
DE
Fiscal year end
December 31
Former names
ORTHODONTIX INC (to 2/22/2007), EMBASSY ACQUISITION CORP (to 3/31/1998)
Latest financial report
10-K - Q4 2024 - Mar 17, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 160 % -15.3%
Quick Ratio 50.1 % -10.7%
Debt-to-equity 136 % -29.3%
Return On Equity 8.75 % -70.6%
Return On Assets 3.71 % -63.5%
Operating Margin 7.34 % -54.1%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 78M shares +6.82%
Common Stock, Shares, Outstanding 75.9M shares +3.97%
Entity Public Float 82M USD -41.1%
Common Stock, Value, Issued 76K USD +4.11%
Weighted Average Number of Shares Outstanding, Basic 72.5M shares +7.43%
Weighted Average Number of Shares Outstanding, Diluted 81.1M shares -1.66%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 53.4M USD -18.5%
Cost of Revenue 24.3M USD +5.82%
Research and Development Expense 13M USD -24.1%
Operating Income (Loss) 3.92M USD -62.6%
Nonoperating Income (Expense) 237K USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 4.15M USD -51.5%
Income Tax Expense (Benefit) 1.22M USD +381%
Net Income (Loss) Attributable to Parent 2.93M USD -64.7%
Earnings Per Share, Basic 0.04 USD/shares -66.7%
Earnings Per Share, Diluted 0.04 USD/shares -55.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 19.8M USD -16.4%
Accounts Receivable, after Allowance for Credit Loss, Current 2.91M USD -44.8%
Inventory, Net 21.2M USD +11.5%
Other Assets, Current 1.1M USD +3.89%
Assets, Current 60.1M USD -14.1%
Deferred Income Tax Assets, Net 2.86M USD -7.63%
Property, Plant and Equipment, Net 4.59M USD -7.68%
Operating Lease, Right-of-Use Asset 5.43M USD -8.11%
Assets 73.4M USD -13%
Accounts Payable, Current 19.6M USD +4.47%
Employee-related Liabilities, Current 1.34M USD -6.54%
Accrued Liabilities, Current 9.57M USD +6.21%
Contract with Customer, Liability, Current 12.7M USD
Liabilities, Current 25.6M USD -43.7%
Operating Lease, Liability, Noncurrent 4.03M USD -12.9%
Liabilities 30.2M USD -40.6%
Retained Earnings (Accumulated Deficit) -378M USD +0.83%
Stockholders' Equity Attributable to Parent 43.2M USD +28.7%
Liabilities and Equity 73.4M USD -13%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 4.19M USD
Net Cash Provided by (Used in) Financing Activities 14.2M USD
Net Cash Provided by (Used in) Investing Activities -606K USD -113%
Common Stock, Shares Authorized 185M shares 0%
Common Stock, Shares, Issued 75.9M shares +3.97%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3.58M USD -77.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 19.8M USD -16.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 766K USD -28.9%
Deferred Tax Assets, Valuation Allowance 50.7M USD -1.85%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure
Operating Lease, Liability 5.53M USD -8.36%
Depreciation 322K USD +15%
Payments to Acquire Property, Plant, and Equipment 598K USD +141%
Lessee, Operating Lease, Liability, to be Paid 7.87M USD -12.9%
Property, Plant and Equipment, Gross 40.3M USD +1.69%
Operating Lease, Liability, Current 1.5M USD +6.46%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.24M USD -11.2%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.5M USD +6.46%
Operating Lease, Weighted Average Discount Rate, Percent 0.13 pure 0%
Deferred Income Tax Expense (Benefit) 236K USD
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.34M USD -22%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.09M USD -3.56%
Deferred Tax Assets, Operating Loss Carryforwards 50M USD -2.83%
Current Income Tax Expense (Benefit) 164K USD +72.6%
Preferred Stock, Shares Authorized 100M shares
Unrecognized Tax Benefits 805K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.04M USD -0.38%
Deferred Tax Assets, Net of Valuation Allowance 2.86M USD -7.63%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares